创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

神经阻滞麻醉联合艾司氯胺酮应用于锁骨骨折切开复位内固定术的临床研究

Clinical Study of Nerve Block Anesthesia Combined with Esketamine in Open Reduction and Internal Fixation of Clavicle Fractures

  • 摘要: 目的 分析神经阻滞麻醉联合艾司氯胺酮应用于锁骨骨折切开复位内固定术的临床价值。方法 选取2023年2月至2024年2月在佛山市中医院三水医院行切开复位内固定术治疗的99例锁骨骨折患者为研究对象,按照随机数字表法分为A组(n=32,单独行神经阻滞麻醉)、B组(n=33,神经阻滞麻醉+右美托咪定术中持续泵入)、C组(n=34,在B组基础上于术中持续泵入艾司氯胺酮)。记录3组的手术与麻醉相关指标,对比其入室时(T0)、切皮即刻(T1)、术中30 min(T2)、术毕(T3)的平均动脉压(mean arterial pressure,MAP)、心率(heart rate,HR)和血氧饱和度(blood oxygen saturation,SpO2),同时采用视觉模拟量表(Visual Analog Scale,VAS)、Richmond躁动-镇静量表(Richmond Agitation-Sedation Scale,RASS)、简易精神状态量表(Mini-Mental State Examination,MMSE)对患者进行评估,并记录不良反应发生情况。结果 C组麻醉药物剂量、镇痛泵按压次数少于A组、B组,麻醉起效及苏醒时间早于A组、B组(P < 0.05)。C组T2时SpO2高于A组、B组,C组T1时、T3时SpO2高于A组(P < 0.05)。C组术后6、12、24 h的VAS评分低于A组、B组(P < 0.05)。C组在T1、T2、苏醒后1 min的RASS评分高于A组、B组(P < 0.05)。C组术后1、3 d的MMSE评分高于A组、B组(P < 0.05)。3组不良反应风险差异无统计学意义(P > 0.05)。结论 神经阻滞麻醉联合艾司氯胺酮用于锁骨骨折切开复位内固定术,可稳定术中血流动力学指标,改善镇静镇痛效果,减少术后认知损害,促进术后恢复。

     

    Abstract: Objective To analyze the clinical value of nerve block anesthesia combined with esketamine in open reduction and internal fixation of clavicle fractures. Methods A total of 99 patients with clavicle fractures who underwent open reduction and internal fixation at Sanshui Hospital, Foshan Hospital of Traditional Chinese Medicine from February 2023 to February 2024 were selected as study subjects. They were divided into three groups using a random number table: Group A (n= 32, receiving nerve block anesthesia alone), Group B (n= 33, receiving nerve block anesthesia combined with continuous intraoperative infusion of dexmedetomidine), and Group C (n=34, based on Group B with additional continuous intraoperative infusion of esketamine). Surgical and anesthesia-related indicators were recorded. Mean arterial pressure (MAP), heart rate (HR), and blood oxygen saturation (SpO2) at baseline (T0), immediately after skin incision (T1), 30 min intraoperatively (T2), and at the end of surgery (T3) were compared. The patients were assessed using the Visual Analog Scale (VAS), the Richmond Agitation-Sedation Scale (RASS), and the Mini-Mental State Examination (MMSE). Adverse reactions were also monitored. Results Compared with Groups A and B, Group C demonstrated a significant reduction in anesthetic dosage and frequency of patientcontrolled analgesia pump activation, alongside a shorter onset of anesthesia and earlier recovery time (P < 0.05). Group C exhibited higher SpO2 at T2 than both Groups A and B, and higher SpO2 at T1 and T3 compared with Group A (P < 0.05). VAS scores at 6, 12, and 24 hours postoperatively were significantly lower in Group C than in Groups A and B (P < 0.05). RASS scores at T1, T2, and 1 minute after awakening were significantly higher in Group C than in Groups A and B (P < 0.05). Similarly, MMSE scores on postoperative day 1 and day 3 were significantly higher in Group C than in Groups A and B (P < 0.05). No statistically significant difference was observed in the incidence of adverse reactions among the three groups (P > 0.05). Conclusion Nerve block anesthesia combined with esketamine in open reduction and internal fixation for clavicle fractures can stabilize intraoperative hemodynamic parameters, improve sedative and analgesic effects, reduce postoperative cognitive impairment, and promote postoperative recovery.

     

/

返回文章
返回